UNSPSC 51372028: Levorphanol tartrate anhydrous

This classification denotes an opioid receptor agonist and opioid with the molecular formula C17H23NO.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WCB1I20F1K, chemically known as morphinan-3-ol, 17-methyl-, [r-(r*,r*)]-2,3-dihydroxybutanedioate (1:1) (salt), but more generally known as levorphanol tartrate anhydrous, which bears US NIH Compound Identifier 5464027.

European Medicines Agency schedules levorphanol tartrate anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08490MIG. Most nations, for tariff purposes, schedule levorphanol tartrate anhydrous under HS 29334100. SMILES: CN1CC[C@]23CCCC[C@H]2[C@H]1CC4C3CC(CC4)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51372028 Levorphanol tartrate anhydrous is a Commodity code for a specific pharmaceutical product, but the recent state and local procurement activity tagged to this code shows a significant mismatch: Seminole County, Florida solicited naloxone and drug deactivation systems, which are distinct products not chemically or therapeutically equivalent to levorphanol tartrate. State and local procurement systems sometimes misclassify pharmaceutical solicitations when cataloging by active ingredient or therapeutic class rather than by the actual product being purchased. The code itself targets a narrow opioid compound used in pain management, yet the recent opportunity record reflects community health and overdose-response procurement. This mismatch suggests the code may see minimal relevant activity in state and local buying, or that issuers are applying the taxonomy inconsistently when posting pharmaceutical purchases.

Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, represents the only recent state and local opportunity visible under this code, and it does not align with levorphanol tartrate procurement. The solicitation calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. This activity spans a single county in central Florida with no additional geographic spread or repeat-buyer pattern visible in the source. The mismatch between the code's nominal pharmaceutical scope and the actual goods being solicited limits the decision relevance of this record for vendors pursuing levorphanol tartrate opportunities in state and local procurement.